21 May 2020
Pirbright African swine fever vaccine protects 100% of pigs from developing severe disease
Scientists from The Pirbright Institute are a step closer in the race to develop a vital vaccine for African swine fever (ASF). In their recent trial, published in Vaccines, 100 percent of pigs immunised with the new vaccine survived a lethal dose of ASF virus. ASF causes fever, loss of appetite…
Read more